All In MedTech

Device Trial Radar · NCT07856342

Megagon Magnet Anastomosis Plus OTOLoc for Creating Colo-colonic and Colorectal Anastomoses

GI Windows Megagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Colo-colonic and Colorectal Anastomoses in Patients Undergoing Surgical Procedures

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Nov 16, 2026

Primary completion

Nov 30, 2026

Study completion Mar 30, 2027

Sponsor

Lead sponsor
GI Windows, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to investigate the safety and effectiveness of the Megagon 28.5mm SFM system plus OTOLoc when used to create a colo-colonic and colorectal anastomosis in participants undergoing colon surgery. This will be evaluated via a composite safety/effectiveness endpoint of patient success defined as successful creation of the target anastomosis without placement procedure, device or target anastomosis related reoperation through 30 days.

Conditions

  • Colo-rectal Anastomosis
  • Colo-rectal Cancer
  • Colo-rectal Surgery

Interventions

  • Megagon Self-Forming MagnetDevice

    Megagon Self-Forming Magnet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EndpointTime frame: 30 Days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.